A biopsy can be described as a process in which a sample tissue is removed from the body for analyzing or discovering the presence, cause, or extent of a disease. The global biopsy devices market is expected to register a CAGR of 6.5% during the forecast period (2018 - 2023).
Increase in the Number of Cancers Cases Worldwide
Cancer prevalence indicates the number of people who were diagnosed with cancer in their lifetime. Prevalence is determined by the repetition of occurrence of cancer and the life expectancy of the patient after diagnosis. The key facts stated by WHO projects cancer to be one of the leading causes of mortality worldwide, with around 14 million new cases and 8.2 million cancer-related deaths in 2012. The number of new cases is expected to rise by 70% in the next two decades. The demand for early detection of the cancer is going to influence the growth of the biopsy devices market in the world over.
Increasing preference for minimally-invasive surgeries and initiatives undertaken by the government and global health organizations, are some of the other factors contributing to the growth of the market.
Risk of Infection
A biopsy is often the key to diagnosis. However, as some of these devices are being re-used, biopsy needle becomes a highly risky source of infection and micro-organisms get inoculated into the body. The needles used for biopsy can never be effectively cleaned or sterilized, and reuse of it can cause the spread of blood borne pathogens, like Hepatitis-B, Hepatitis-C, and HIV, as well as other micro-organisms like atypical mycobacteria, gram negative bacteria, and various fungi infections.
Additionally, increasing product recalls, due to unmet regulations, is also restraining the global biopsy devices market growth.
Asia-Pacific to have the Highest CAGR in Biopsy Devices Market
The global biopsy devices market is segmented by product, application and geography. By geography, it is segmented into North America, Europe, Asia-Pacific, the Middle East & Africa, and South America.
The growth of Asia-Pacific can be attributed to the rising prevalence of cancer, large population in countries such as China and India, improving healthcare infrastructure, increasing healthcare spending and government initiatives, and rising focus of key market players in the region.
Key Developments in the Biopsy Devices Market
August 2017: C. R. Bard Receives FDA pPremarket approval of the LUTONIX® 035 drug coated balloon as the first and only DCB for the treatment of patients with dysfunctional AV fistulae
August 2017: Hologic announced the availability of New Brevera® Breast Biopsy System, with CorLumina® Imaging Technology
Biopsy Devices Market Key Players:
- C. R. Bard, Inc.
- Hologic Inc.
- Dickinson and Company.
- Devicor Medical Products, Inc.
- Cook Medical.
- Boston Scientific Corporation.
- Intact Medical Corporation.
- Gallini Medical.
- TSK Laboratory.
Reasons to Purchase Biopsy Devices Market Report
- Market analysis for the Global Biopsy Devices Market, with region-specific assessments and competition analysis on a global and regional scale
- Analyze various perspectives of the industry with the help of Porter’s five forces analysis
- The treatment type that is expected to dominate the market
- Regions that are expected to witness the fastest growth, during the forecast period
- Identify the latest developments, market shares, and strategies employed by the major market players
- 3-month analyst support, along with the market estimate sheet (in excel)
Customize Biopsy Devices Market Report
- This report can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter's Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Products and Services
5.2.5 Competitive Rivalry within the Industry
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Increasing Preference for Minimally Invasive Surgeries
6.1.2 Initiatives Undertaken by Government and Global Health Organizations
6.1.3 Increase in the Number of Cancer Cases Worldwide
6.2 Market Restraints
6.2.1 Product Recalls
6.2.2 Risk of Infections
6.4 Key Challenges
7. Market Segmentation
7.1 By Product
7.1.1 Needle-based biopsy Instruments
126.96.36.199 Core Biopsy Devices
188.8.131.52 Aspiration Biopsy Needles
184.108.40.206 Vacuum-Assisted Biopsy Devices
7.1.2 Procedure Trays
7.1.3 Localization Wires
7.2 By Application
7.2.1 Breast Biopsy
7.2.2 Lung Biopsy
7.2.3 Colorectal Biopsy
7.2.4 Prostate Biopsy
7.3 By Geography
7.3.1 North America Biopsy Devices Market Analysis (2018-2023)
220.127.116.11 United States Biopsy Devices Market Analysis (2018-2023)
18.104.22.168 Canada Biopsy Devices Market Analysis (2018-2023)
22.214.171.124 Mexico Biopsy Devices Market Analysis (2018-2023)
7.3.2 Europe Biopsy Devices Market Analysis (2018-2023)
126.96.36.199 France Biopsy Devices Market Analysis (2018-2023)
188.8.131.52 United Kingdom Biopsy Devices Market Analysis (2018-2023)
184.108.40.206 Germany Biopsy Devices Market Analysis (2018-2023)
220.127.116.11 Italy Biopsy Devices Market Analysis (2018-2023)
18.104.22.168 Spain Biopsy Devices Market Analysis (2018-2023)
22.214.171.124 Rest of Europe
7.3.3 Asia-Pacific Biopsy Devices Market Analysis (2018-2023)
126.96.36.199 India Biopsy Devices Market Analysis (2018-2023)
188.8.131.52 China Biopsy Devices Market Analysis (2018-2023)
184.108.40.206 Japan Biopsy Devices Market Analysis (2018-2023)
220.127.116.11 Australia Biopsy Devices Market Analysis (2018-2023)
18.104.22.168 South Korea Biopsy Devices Market Analysis (2018-2023)
22.214.171.124 Rest of APAC
7.3.4 Middle East & Africa Biopsy Devices Market Analysis (2018-2023)
126.96.36.199 GCC Biopsy Devices Market Analysis (2018-2023)
188.8.131.52 South Africa Biopsy Devices Market Analysis (2018-2023)
184.108.40.206 Rest of Middle East & Africa
7.3.5 South America Biopsy Devices Market Analysis (2018-2023)
220.127.116.11 Brazil Biopsy Devices Market Analysis (2018-2023)
18.104.22.168 Argentina Biopsy Devices Market Analysis (2018-2023)
22.214.171.124 Rest of South America
8. Biopsy Devices Market Competitive Landscape
8.1 Mergers and Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Product Launches
9. Biopsy Devices Market Key Players
9.1 C. R. Bard, Inc.
9.2 Hologic Inc
9.3 Becton, Dickinson and Company
9.4 Devicor Medical Products, Inc.
9.5 Cook Medical
9.6 Boston Scientific Corporation
9.7 Intact Medical Corporation
9.8 Gallini Medical
9.9 TSK Laboratory Europe B.V.
10. Future of the Biopsy Devices Market